TrademarksHub.

UAE trademark · No. 385187

DOLOPAR — UAE trademark

status
Registered
class
5 · Pharmaceuticals & medical preparations
filed
15 Oct 2022
DOLOPAR — UAE trademark, Class 5, No. 385187
Registered

Renewal window: 15 October 2031 to 15 October 2032 (+6 months grace at a higher fee).

Trademark details

MarkDOLOPAR
Application number385187
Registration number385187
ClassClass 5 Pharmaceuticals & medical preparations
StatusRegistered
Filing date15 October 2022
Published31 May 2023 · Bulletin No. 271
Registered30 July 2023
Expires / renewal due15 October 2032

About this trademark

“DOLOPAR” is a trademark on the UAE register, filed on 15 October 2022 under application number 385187.

It covers Class 5 (Pharmaceuticals & medical preparations).

It was accepted and published in the UAE Trademark Bulletin No. 271 on 31 May 2023.

It was registered on 30 July 2023.

The registration runs until 15 October 2032 — 10 years from filing — and can be renewed in the last year before that date.

Goods and services

As filed with the Ministry of Economy and Tourism (in Arabic). Protection covers only what is listed.

مستحضرات صيدلانية وبيطرية مستحضرات صحية لغايات طبية، مواد وأغذية حمية معدة للإستعمال الطبي أو البيطري وأغذية للرضع والأطفال، مكملات للحمية الغذائية للإنسان والحيوان؛ لصقات ومواد ضماد، مواد حشو ،الأسنان وشمع طب الأسنان، مطهرات ،مستحضرات لإبادة الحشرات والحيوانات الضارة مبيدات فطريا.ت ومبيدات أعشاب

Mark description: كتبت بأحروف لاتينية DOLOPAR بأحرف عادية بالأبيض والأسود

Gazette history

  • Accepted and published for opposition · No. 27131 May 2023
  • Registered · No. 27531 July 2023

Similar UAE trademarks

Similar by name. See all similar marks · Check your own name

Explore

Class 5 explainedClass 5 marks open for opposition Status check

Source: UAE Trademark Bulletin (Ministry of Economy and Tourism) as read by TrademarksHub; renewal date worked out from the filing date. Trademark data only — owner details are not published on this site. Check the official register before acting. Not legal advice.